Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Mater 32 (27), 1904337
Oncologist Coral Omene at Rutgers Cancer Institute, for example, plans to follow 40 breast cancer patients starting tirzepatide, a GLP-1 drug sold under the brand names Mounjaro and Zepbound
All anti obesity medications including semaglutide, tirzepatide, and liraglutide, may carry gastrointestinal adverse events such as abdominal pain, decreased appetite, and nausea, and they should be used under close medical supervision, particularly in individuals with a family medical history of thyroid cancer, or existing cardiovascular disease, chronic kidney disease, or risk of heart attack
10.1016/j.freeradbiomed.2005.08.033 Free Radic
Avoid GLP-1 Counteracting Foods and Habits Some foods and habits can work against the medication by triggering cravings or worsening side effects like nausea
Patients with type 2 diabetes and elevated BMI are among the most clinically well-supported candidates for GLP-1 treatment
